Pharma channel feed

CMS spent more than $18B in four years on ac­cel­er­at­ed ap­provals with in­com­plete con­fir­ma­to­ry tri­als, in­spec­tor gen­er­al finds

3 years ago
FDA+

Some­one old, some­one new: Mod­er­na pro­motes CTO, raids No­var­tis for re­place­ment amid pipeline push

3 years ago
People

Sanofi, Re­gen­eron’s Dupix­ent scores an­oth­er in­di­ca­tion with first-ever ap­proval for nodu­lar skin dis­or­der

3 years ago
FDA+

Pa­tient re­port finds con­sti­pa­tion con­di­tion not well-man­aged, open­ing door for bet­ter ed­u­ca­tion from phar­ma

3 years ago
Marketing

Gilead names 'k­ing­pin­s' in coun­ter­feit HIV med law­suit

3 years ago
Law

Vor Bio opts to keep man­u­fac­tur­ing op­er­a­tions in-house for de­vel­op­ing stem cell, CAR-T ther­a­pies

3 years ago
Manufacturing

Tar­sus looks to raise aware­ness of eye­lid mite dis­ease in cam­paign aimed at eye­care spe­cial­ists

3 years ago
Marketing

An­oth­er Avastin biosim­i­lar joins the par­ty as Roche's grip on the mar­ket loosens

3 years ago

As win­ter ap­proach­es, a Eu­ro­pean gener­ics group rais­es alarm over en­er­gy prices for man­u­fac­tur­ers

3 years ago
Manufacturing

What more can we learn from DTC ad­ver­tis­ing? FDA's OPDP pro­pos­es new re­search

3 years ago
FDA+

Sanofi us­es cre­ative cam­ou­flage in physi­cian-tar­get­ed cam­paign for po­ten­tial can­cer bio­mark­er

3 years ago
Marketing

J&J de­buts Ken­vue as new name for $15B con­sumer health busi­ness spin­off

3 years ago
Marketing

CMS as gate­keep­er: Why lecanemab is sim­i­lar but al­so very dif­fer­ent from Aduhelm

3 years ago

New Jer­sey biotech nets $50M+ BAR­DA con­tract for res­pi­ra­to­ry can­di­date

3 years ago
R&D

Up­dat­ed: Does R&D spend link to fi­nal mar­ket price? Aca­d­e­mics say 'no' in new pa­per

3 years ago

Ab­b­Vie teams up with Shut­ter­stock to re­de­fine beau­ty in lat­est aes­thet­ics cam­paign

3 years ago
Marketing

Genen­tech de­buts next it­er­a­tion of its Ocre­vus MS cam­paign, tar­get­ing GenZ and His­pan­ic au­di­ences

3 years ago
Marketing

Man­u­fac­tur­ing sites in Ger­many and Chi­na hit with warn­ing let­ters over QC and clean­ing is­sues

3 years ago
FDA+
Manufacturing

From Covid ad boom to en­dem­ic: Track­ing TV ads from first rush of brand ca­ma­raderie to to­day’s phar­ma boost­ers

3 years ago
Marketing

UK reg­u­la­tors cau­tion against switch­ing be­tween com­mon AD­HD meds

3 years ago

Mar­ket­ingRx roundup: Mod­er­na en­cour­ages fall boost­ers; Roche's Genen­tech amps its STEM di­ver­si­ty pro­gram

3 years ago
Marketing

Emer­gent clos­es on buy­ing small­pox drug Tem­bexa from Chimerix with a $238M pay­ment

3 years ago
Deals
Manufacturing

Bio­gen pays $900M to set­tle wide-rang­ing physi­cian kick­back claims

3 years ago
Law

Even as pan­dem­ic re­cedes, short-staffed tri­al sites leave can­cer pa­tients wait­ing

3 years ago
R&D
In Focus
First page Previous page 170171172173174175176 Next page Last page
A service from the Financial Times